Why do the world’s largest pharmaceutical and clinical research organizations turn to eStudySite for rapid enrollment and quality research?
Because providing clinical research is not a side-business for us; it’s our only business. It’s why we developed and perfected a system unmatched for efficiencies in rapidly screening and enrolling large numbers of study subjects. The benefits to sponsors and CROs are clear: speedier results and greater cost savings.
We boast one of the largest HIPAA-compliant, geo-diverse subject databases available. In fact, our patented database system, together with our staff of well-trained expert investigators and coordinators at multiple study sites, yields the highest quality research data that will help you greatly accelerate the approval process timeline.
Put our team of critical care and research professionals to work on your next study. Take advantage of their training, experience and expertise in providing exceptional team care. Discover why we are the most efficient and productive inpatient and outpatient research site in the world. | | | | Complicated Skin Infection Study Example | This Phase II Complicated Skin Infection Study required an open enrollment target of 500 subjects. The study Sponser defined a narrow inclusion criteria for potential study subjects, and imposed a 24 month enrollment deadline for all 500 patients. In addition to eStudySite, 37 other sites were also asked to enroll. | 97% enrollment rate,
10 months ahead of schedule | Using our unique methodology, eStudySite successfully enrolled 483 of the subjects required for this study and completed the TOC on all of the patients in 14 months, shaving 10 months off the Sponsor's Phase II study arm timeline. The remaining 37 sites enrolled a combined total of 17 subjects during the same time frame. |
|
